Table 3.
Univariable |
Multivariable |
|||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age (≥73) | 1.79 | 1.27–2.54 | 0.0009 | 1.55 | 0.98–2.51 | 0.0636 |
initial PSA (≥485) | 0.92 | 0.65–1.29 | 0.6248 | - | - | - |
GS ≥ 9 | 1.66 | 1.11–2.54 | 0.0127 | 1.47 | 0.87–2.59 | 0.1499 |
T stage (≥T3b) | 1.75 | 1.12–2.90 | 0.0137 | 1.14 | 0.63–2.21 | 0.6755 |
N stage (positive) | 2.00 | 1.35–3.04 | 0.0004 | 1.66 | 0.99–2.90 | 0.0555 |
Hb (<13.3) | 1.4 | 0.99–2.01 | 0.0575 | - | - | - |
LDH (≥ 205) | 2.31 | 1.61–3.35 | < 0.0001 | 2.63 | 1.62–4.36 | < 0.0001 |
ALP (≥352) | 1.61 | 1.11–2.39 | 0.0118 | 1.52 | 0.93–2.54 | 0.1003 |
NLR (≥2.6) | 0.77 | 0.54–1.11 | 0.1641 | - | - | - |
CRP (≥ 0.19) | 2.06 | 1.32–3.29 | 0.0013 | 1.65 | 1.02–2.73 | 0.0420 |
ALP, alkaline phosphatase; CI, confidence interval; CRP, C-reactive protein; GS, Gleason score sum; Hb, haemoglobin; HR, hazard ratio; LDH, lactate dehydrogenase; NLR, neutrophil-lymphocyte ratio; PSA, prostate-specific antigen.